Asciminib in patients with newly diagnosed chronic myeloid leukemia: results from the Japanese subgroup of ASC4FIRST. - Takahashi N; Kikushige Y; Nakamae H; Goto T; Tomita A; Ichii M; Ito S; Teshima T; Kirito K; Ikezoe T; Hatano K; Tanaka H; et al. (International journal of hematology, 2025)